Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Medicinova (MNOV) Invested Capital (2021 - 2025)

Medicinova (MNOV) has disclosed Invested Capital for 7 consecutive years, with $41.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital changed N/A to $41.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $41.6 million, a N/A change, with the full-year FY2025 number at $41.6 million, changed N/A from a year prior.
  • Invested Capital was $41.6 million for Q4 2025 at Medicinova, down from $44.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $92.4 million in Q1 2021 to a low of $41.6 million in Q4 2025.
  • A 5-year average of $66.5 million and a median of $64.9 million in 2023 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: decreased 11.54% in 2023, then decreased 20.16% in 2025.
  • Medicinova's Invested Capital stood at $83.7 million in 2021, then fell by 12.63% to $73.1 million in 2022, then dropped by 14.67% to $62.4 million in 2023, then fell by 11.72% to $55.1 million in 2024, then dropped by 24.48% to $41.6 million in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Invested Capital are $41.6 million (Q4 2025), $44.0 million (Q3 2025), and $46.9 million (Q2 2025).